Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
763.32-
QQQ
710.050.94%
BTC/USD
78149.530.524%
DIA
528.740.53%
GLD
401.961.58%
TLT
81.820.47%

Spero Therapeutics Inc

SPRONASDAQ
Trade with Public
Trade with Public
$1.22
0.021.67%
At close: Aug 28, 5:00 PM EST
$1.20
0.00160.13%
Pre-Market: 7:01 AM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Spero Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Spero Therapeutics (SPRO).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

2Buy
2Hold
Consensus RatingIn-Line# Analysts4Avg. Consensus PT$5Upside to Avg. PT+316.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Jan 30, 2025HC Wainwright & Co.Raghuram SelvarajuMaintainedBuy$5
Dec 20, 2024Evercore ISI GroupJosh SchimmerDowngradeOutperform→In-Line$5
More with Benzinga EdgeGet Access

Analyst Ratings News

Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields

Avi Kapoor

The Analyst Verdict: Spero Therapeutics In The Eyes Of 4 Experts

Benzinga Insights

PRO
HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $5 price target.
Benzinga Newsdesk

What 4 Analyst Ratings Have To Say About Spero Therapeutics

Benzinga Insights

PRO
Evercore ISI Group Downgrades Spero Therapeutics to In-Line, Maintains Price Target to $5

Evercore ISI Group analyst Josh Schimmer downgrades Spero Therapeutics (NASDAQ:SPRO) from Outperform to In-Line and maintains the price target from $5 to $5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Spero Therapeutics, Maintains $5 Price Target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Spero Therapeutics (NASDAQ:SPRO) with a Buy and maintains $5 price target.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved